OpenRounds Editorial
Daily Briefing
Wednesday, April 29, 2026
What Changed
Utah's medical board forced immediate suspension of an AI prescription renewal pilot, marking a direct state regulatory intervention against autonomous clinical AI deployment, while new evidence continues to sharpen the case for structured LLM output formats and multi-AI verification as practical governance mechanisms [1][2][3][4].
Research
•[AI in Clinical Practice] Chain-of-thought LLM explanations boosted radiologist diagnostic accuracy by 12.2% versus no support and outperformed standard AI output by 7.2% and differential diagnosis formats by 9.7% in a randomized study of 2,020 assessments published in NPJ Digital Medicine [3]. The format comparison is the operationally useful finding: departments configuring LLM-assisted reads should explicitly specify chain-of-thought output rather than defaulting to summary-style responses, as the evidence shows format choice—not mere access to AI—drives the accuracy difference.
•[AI Evidence] Large-scale BMJ Health & Care Informatics testing using simulated case vignettes across hypercholesterolaemia and type-2 diabetes scenarios found DeepSeek-V3 omitting relevant clinical guidelines in up to 97% of cases and GPT-4.1 in 46%, with both models showing additional sensitivity to patient location and sociodemographic characteristics [4]. The vignettes held medical information constant while varying demographics, isolating guideline omission and bias as structural rather than edge-case problems—a design that gives health system AI governance teams a replicable testing template before clinical deployment.
Policy & Ops
•[AI in Clinical Operations] Utah's medical board invoked its regulatory authority to demand immediate suspension of a state-sponsored pilot program using an AI bot to renew prescriptions, citing safety and oversight concerns [2]. The intervention is notable because the board acted against a state government pilot rather than a private vendor deployment, signaling that medical board authority extends to publicly sponsored programs and that pilot status alone does not insulate autonomous clinical AI from regulatory halt.
•[AI in Clinical Operations] Speaking on the Healthcare AI Pioneers podcast, UCSF's Dr. Bob Wachter describes "AI looking over the shoulder of AI" as the practical answer to 365-day reliability requirements in high-stakes clinical monitoring, noting that human-in-the-loop review cannot sustain the consistency continuous-run systems demand [1]. He acknowledges the recursive challenge—the verification AI must itself be trustworthy—but argues a second model tuned specifically to audit the first is more tractable than scaling human oversight for always-on applications, a design assumption that clinical operations teams should build into governance frameworks from the start rather than address after deployment.